Pfizer Inc. (NYSE:PFE) finally saw a slight correction in the rally that had started with April 1. The last week began on a good note but as weekend approached, a majority of the gains made earlier in the week were wiped out. However, in terms of … [Read more...]
Pfizer Inc. (PFE) Research Could be Boon for Parkinson’s Patients
Pfizer Inc. is turning its focus to the Internet of Things (IoT) in medicine as it seeks to reduce reliance on drugs for growth. The company wants to connect physical equipment such as diagnostic devices to gather and share data in order to boost … [Read more...]
Pfizer Inc. (NYSE:PFE) Tries to Dodge $35bn in Taxes, Analysts Bullish
Pfizer Inc. is aiming to dodge about $35bn in taxes. This will happen as a result of the planned merger with Allergan. Allergan is based in Ireland and that is where Pfizer is wanting to move its headquarters. Currently Pfizer is based in New York. … [Read more...]
Alibaba Group’s Quest for China’s $100 Billion Retail Drug Market Stalls
Alibaba Group Holding Ltd. has sailed into headwinds in its plans to conquer China’s medical market by prescribing and selling drugs through an online platform. Chinese officials shut down a government-owned drug tracking system that was created and … [Read more...]
Bristol-Myers Squibb Co (NYSE:BMY) Stock has 25% Upside – Barron’s
Bristol-Myers Squibb Co stock has 25% upside potential amid the success of its new cancer-fighting drug Opdivo, writes Sandra Ward, Senior Editor at Barron’s. Opdivo has so far proved to be the most successful of the new class of … [Read more...]
Pfizer Inc. (NYSE:PFE) Deserves a Place in Your Portfolio – Analyst
Pfizer Inc. deserves a place in your portfolio, according to Andrew McNair, Founder and CEO of Swan Capital. Shares of Pfizer were largely flat in 2015. But the pharma major's decision in November to buy Allergan for $160 billion made big news. … [Read more...]
Pfizer Inc (PFE) Lures Institutional Investors in Hordes
Pfizer Inc. stock continues to attract hordes of institutional investors, if the heightened purchasing activity witnessed recently is anything to go by. EQIS Capital Management raised its position in Pfizer by 350.9% in the fourth quarter, its … [Read more...]
Pfizer Inc. (PFE)’s Obsession with ‘Tax Rate’ is Hurting Shareholders
Pfizer Inc. has agreed to buy Botox maker Allergan Plc for a whopping $160 billion to lower its U.S. tax bill. The acquisition would create the world's biggest drug maker, and shift Pfizer's headquarters to Ireland. But Bernard Munos, founder of … [Read more...]
Regeneron Pharmaceuticals Inc Leads Jim Cramer’s Picks for 2016
Regeneron Pharmaceuticals Inc and Biogen Inc are Jim Cramer’s top picks for 2016. Cramer has been a long-time votary of the group of stocks he calls the “four horsemen of big pharma” that also include Gilead Sciences, Inc. and Celgene Corporation … [Read more...]
KaloBios Pharmaceuticals Inc (NASDAQ:KBIO) Stock Surge – Street Says Beware
KaloBios Pharmaceuticals Inc shot up close by almost 50% in Friday pre-market trading. CEO Martin Shkreli said on Twitter that he would not lend any more of his stock to short sellers. Popular blogger The Fly cited Markit data to indicate … [Read more...]
Eli Lilly and Co (NYSE:LLY) Stock Receives Major Cancer Drug Boost
Eli Lilly and Co shares surged in New York pre-market trading after the U.S. Food and Drug Administration approved its drug to treat an advanced form of lung cancer. The FDA said Portrazza could be used in conjunction with two other chemotherapy … [Read more...]
Valeant Pharmaceuticals Intl Inc (VRX) Gets Loving Bump from Pershing
Valeant Pharmaceuticals Intl Inc ’s stock should see brisk activity on Tuesday. Bill Ackman said his hedge fund Pershing Square Capital has raised its stake in the embattled drug maker from 5.7% to 9.9%. The share buys were made in a series of … [Read more...]
Valeant Pharmaceuticals Intl Inc (NYSE:VRX) Discount Strategy Intends to ‘Protect’ Volume
Valeant Pharmaceuticals Intl Inc is resorting to discounts to lift demand. Bloomberg News reports that after facing much criticism for its price hikes, the drug maker is turning to the new strategy to ‘protect volume.’ Valeant Chooses Sales over … [Read more...]
Pfizer Inc. (PFE) Allergan plc (AGN) Buy Could Mean ‘More Taxes’
Pfizer Inc. last week acknowledged that it had begun merger talks with Allergan PLC . The goal is pretty straight forward. Pfizer Inc. wants to achieve the tax inversion, it has so badly been seeking for some time. Last year, it aggressively tried … [Read more...]
Valeant Pharmaceuticals Intl Inc (VRX) Stock Is Still A Great Buy – Wall Street
Valeant Pharmaceuticals Intl Inc shares took a fall on Thursday. The firm’s stock took a heavy dive after Citron Research accused it of conducting irregular accounting practices. Following the accusations, shares fell as much as 40 percent before … [Read more...]
Johnson & Johnson (NYSE:JNJ) Shows Off Mixed Third Quarter Results
Johnson & Johnson , right before the market opened on Tuesday 13, October, showed off its earnings numbers for the three months through September. Earnings for the quarter came in at $1.49. The firm showed sales totaling $17.1B for the three … [Read more...]
Pfizer Inc. (PFE) Makes Two-Pronged Cancer Attack Bet
Pfizer Inc. is world's second-biggest drug maker by revenue. Yet, a decade ago, it wasn't even a player in the cancer space. Instead, two drugs brought in the chunk of its sales - cholesterol drug Lipitor, and erectile dysfunction treatment … [Read more...]
Eli Lilly & Co (NYSE:LLY) Stock Dives After “Cholesterol-Killer” Killed
Eli Lilly and Co shares were set to open more than 10 percent below Friday's close on Monday morning, October 12, after the firm revealed that it would stop the making of evacetrapib. The drug, which targets cholesterol, was seen as a major hope … [Read more...]
Pfizer Inc. (NYSE:PFE) is a Buy at Current Levels – Jim Cramer
Pfizer Inc. is a great stock, Jim Cramer said on Mad Money on Thursday. CEO Ian Read is doing some good things with the pharma giant, and Cramer advises investors to start buying into the stock. This may seem contradictory at a time when drug … [Read more...]
Walt Disney (DIS), Aetna (AET), CVS Health (CVS), Scripps Networks Interactive (SNI) – Earnings in Focus
Walt Disney Co , Aetna Inc , CVS Health Corp and Scripps Networks Interactive, Inc. will report quarterly results on Tuesday. Here’s what investors can expect: Walt Disney Co Walt Disney Co is scheduled to report fiscal third-quarter … [Read more...]